LENVIMA® is generally covered by Insurance Companies, Medicare and Medicaid. Coverage may vary based on the specific type of insurance you have and your Healthcare Provider. Ask your Healthcare Provider about how your insurance will cover LENVIMA®.
Understanding your insurance coverage is the first step in getting your treatments covered. In most cases, this is going to start with your healthcare provider contacting your insurance company. For LENVIMA®, Specialty Pharmacies can oversee the process and assist you and your Healthcare Provider in managing your coverage. Specialty Pharmacies deliver specialized medicines for complex diseases. Your Specialty Pharmacy is an important part of your health care team. They will mail your medication directly to you. The Specialty Pharmacy will help you from the start of therapy and will be in regular contact with you throughout your treatment.
LENVIMA® can also be dispensed through select eligible physician office/clinic or hospital pharmacies. Your doctors office can help you understand your coverage for LENVIMA®.
Once your coverage has been established you can explore your alternatives. If your insurance covers most of your treatment costs, there may be assistance paying the copays on your medications. Eisai's Patient Assistance Program may be available for eligible uninsured and financially burdened patients who have been prescribed LENVIMA. Contact your Healthcare Provider to start understanding your coverage needs and determine eligibility for assistance.
One of the ways you can obtain LENVIMA® is through our Specialty Pharmacy Partners.
LENVIMA® is available through 5 Specialty Pharmacies that will mail the medication directly to you. Patients receiving LENVIMA® from these Specialty Pharmacies—Accredo, Biologics, CVS Specialty, Onco360 or Optum—will be automatically enrolled in our Patient Support Program upon consent which will provide help throughout the treatment journey. Please see below for a list of services that are provided through the Patient Support Program.
Coverage and financial assistance for LENVIMA® are also available to eligible patients who fill their prescription through physician office/clinic or hospital pharmacies.
LENVIMA® is available through eligible provider offices/clinics or hospital pharmacies. Patients receiving LENVIMA® can enroll in our Patient Support Program which will provide help throughout the treatment journey via the LENVIMA® Eisai Assistance Program Enrollment Form or by calling the Eisai Assistance Program at 1-866-61-EISAI (1-866-613-4724).
Please see below for a list of services that are provided through the Patient Support Program.
Eisai offers financial assistance to eligible patients who can’t afford LENVIMA®. Talk to your Healthcare Provider about what assistance options may be available to you. The Eisai Assistance Program can assist you with understanding your options and can be reached at 1-866-61-EISAI or 1-866-613-4724.
Eisai cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record.
What is LENVIMA?
LENVIMA is a prescription medicine that is used to treat certain kinds of cancer.
It is not known if LENVIMA is safe and effective in children.
The most common side effects of LENVIMA in people treated for thyroid cancer include tiredness, joint and muscle pain, decreased appetite, weight loss, nausea, mouth sores, headache, vomiting, rash, redness, itching, or peeling of your skin on your hands and feet, stomach (abdomen) pain, and hoarseness.
The most common side effects of LENVIMA in people treated for kidney cancer include tiredness, joint and muscle pain, decreased appetite, vomiting, nausea, mouth sores, swelling in your arms and legs, cough, stomach (abdomen) pain, trouble breathing, rash, weight loss, and bleeding.
The most common side effects of LENVIMA in people treated for liver cancer include tiredness, decreased appetite, joint and muscle pain, weight loss, stomach (abdomen) pain, rash, redness, itching, or peeling of your skin on your hands and feet, hoarseness, bleeding, change in thyroid hormone levels, and nausea.
LENVIMA may cause fertility problems in males and females. Talk to your healthcare provider if this is a concern for you.
These are not all the possible side effects of LENVIMA. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.
For more information about LENVIMA, please see full Prescribing Information.
The information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care professional. All decisions regarding patient care must be made with a health care professional, considering the unique characteristics of the patient.
This site is intended for residents of the United States only. Any products discussed herein may have different product labeling in different countries.